Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
eNq1mF9v2jAUxd/5FFHeSfjXQacA2li7IbUqo0Wb9lKZ5FLMgp1e20D36ecQusLkqK3Bj8Th+Nr3+OejRP3NMvVWgIJy1vXrQc33gMU8oeyh60/uLqsdv9+rRAuyInuvtYNaUG/4XpwSIbp+PhpMgTAR/Ly++gL6/4B+r+JFfLqAWB68pyRNg29EzK9Jlr/jRStOE28Jcs6Trp8puX3qRUKirqK35vhbZCSGKNw92R9d3Lf2n0dhLvYGVSUArwh7MIrO0EozVojA5IBIeOD4ZJaO7xud9odarWM1BRVjEFxhDCMi5yPkK5pAYp6JpAKsJpmtk1vAVQoyn8QoHi7ipbASJwuyGcPj0Fz0Jz06kBtZrVXr7XbnrN5qtM/Om3Y9xr2tMptHLyLM7pv1VrNVPw9nGDKyVEK7tbqEDdUbQBlY9mnEUZLUUYeoGBx6zdE8CI+vOiGhIkvJU7AQme1WESR6GFATwd1C8hXcoWZUqvfsP32m0jR8Z9WTHUEcVZwDasAVkyUguRzbbsSAMwmb8o7asU9udl6kIE4n+4czM/dHaprS2BZvGkAKhJyMh+V0cwWGz0TABN2R4QdlCV+L0xNnv8OOqs+20DSK6m7Uzjq2V0F+mn5pL5VcOxcKeQahBhEVx/BlyGb8WLJoe5qlns3pxJfbPMRjkkJJIqpaAkcb8jnAObO8u+NUDBhFv17c2VrluwJ8ut3+NErTpPuvyXY0doF4bczXCi/Ob/e4s1qIvCFFtzrNhp3Z0cyYuZSZ+BiG6/U6mBNRFURvY6BP2Zvug/5JVq9B+9I8dwHfSQgoQlHBWUelT4vb833tsz2nr8WEY6Pv7v+7iG2cQ6KCI3pRIN0ZeIcXp2f5S+51VvbogDDuptlmVCIpZ67ykpqWhaUjbg/dV3aJGhA3sxkt+e5S6ssoLL759CpRmH/v6VX+AmTnCLA=
GcAUXySQnDQ2EyZa
Français